Expression and effect of transforming growth factor-α and tumor necrosis factor-α in human pheochromocytoma

Annals of the New York Academy of Sciences

Volumn 1073, Issue , 2006, Pages 277-283

  Tong, An Li ^a   Zeng, Zheng Pei ^a   Li, Han Zhong ^a   Yang, Di ^a   Lu, Lin ^a   Li, Ming ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Apoptosis; Expression; Pheochromocytoma; Proliferation; TGF ; TNF

Indexed keywords

RECOMBINANT CYTOKINE; RECOMBINANT TRANSFORMING GROWTH FACTOR ALPHA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ADRENAL MEDULLA; APOPTOSIS; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; PHEOCHROMOCYTOMA; PHEOCHROMOCYTOMA CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 33845506928     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1353.031     Document Type: Conference Paper

References (13)

1. KOBAYASHI, K. et al. 2000. Immunohistochemical localization of transforming growth factor alpha in chemically induced rat hepatocellular carcinomas with reference to differentiation and proliferation. Toxicol. Pathol. 28: 664-667.
2. KEE, K.H. et al. 2001. Oncoprotein changes in the flat lesions with atypia and invasive neoplasms of the urinary bladder. Oncol. Rep. 8: 579-583.
3. DRIMAN, D.K. et al. 1992. Transforming growth factor-α in normal and neoplastic human endocrine tissues. Hum. Pathol. 23: 1360-1365.
4. MOCELLIN, S. et al. 2005. Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev. 16: 35-53.
5. Wu, S. et al. 1993. Tumor necrosis factor α as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor α expression. Cancer Res. 53: 1939-1944.
6. ROLFE, M. et al. 1997. Tumor necrosis factor α (TNF α) suppresses apoptosis and induces DNA synthesis in rodent hepatocytes: a mediator of the hepatocarcinogenicity of peroxisome proliferators? Carcinogenesis 11: 2277-2280.
7. TONG, A.L. et al. 2003. The primary culture and identification of human pheochromocytoma cells. Basic Med. Clin. 23: 447-450.
8. FASSNACHT, M. et al. 2003. N-terminal proopiomelanocortin acts as a mitogen in adrenocortical tumor cells and decreases adrenal steroidogenesis. J. Clin. Endocrinol. Metab. 88: 2171-2179.
9. AKAO, Y. et al. 2002. Ceramide accumulation is independent of amptothecin-induced apoptosis in prostate cancer LNCaP cells. Biochem. Biophys. Res. Commun. 294: 363-370.
10. NILSSON, O. et al. 1995. Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumors. Int. J. Cancer 60: 645-651.
11. CALL, G.B. et al. 2000. Bovine adrenal cells secrete interleukin-6 and tumor necrosis factor in vitro. Gen. Comp. Endocrinol. 118: 249-261.
12. ROBERT, L.E. et al. 1992. Interleukin-1α and tumor necrosis factor-α differentially regulate enkephalin, vasoactive intestinal polypeptide, neurotensin, and substance P biosynthesis in chromaffin cells. Endocrinology 130: 2252-2258.
13. Wu, S. et al. 1992. Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-α. Am. J. Obstet. Gynecol. 166: 997-1007.